Harm H.E. van Melick

Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib

Axel Bex, Peter F.A. Mulders, Michael A.S. Jewett et al. · JAMA Oncology · 2018 · 490 citations · Full text

Medicine, Oncology, Surgery +17

The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies

Olivier Wegelin, Leonie Exterkate, Marloes van der Leest et al. · European Urology · 2018 · 286 citations

Medicine, Oncology, Urology +17

PREVALENCE AND BOTHERSOMENESS OF LOWER URINARY TRACT SYMPTOMS IN BENIGN PROSTATIC HYPERPLASIA AND THEIR IMPACT ON WELL-BEING

Mardy D. Eckhardt, Ger E.P.M. van Venrooij, Harm H.E. van Melick et al. · The Journal of Urology · 2001 · 147 citations

Medicine, Urology, Andrology +13

Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

Marc‐Oliver Grimm, Antoine G. van der Heijden, Marc Colombel et al. · European Urology · 2020 · 133 citations

Medicine, Oncology, Urology +8

Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer

Ludwike W. M. van Kalmthout, Harm H.E. van Melick, Jules Lavalaye et al. · The Journal of Urology · 2019 · 112 citations · Full text

Medicine, Oncology, Urology +17